Agenus Inc's Form 4 filing
MiNK Therapeutics, Inc. (INKT) · filed Oct 20, 2021
- Accession no.
- 0000899243-21-040873
- Filed
- Oct 20, 2021
- Trade date
- Oct 19, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $16.8M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Agenus IncCIK 0001098972 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 19, 2021 | Common Stock | PPurchaseAcquired | +1,400,000 | $12.00 | +$16,800,000 | 20,881,000 | Direct | |
| Oct 19, 2021 | Common Stock | CConversionDisposed | −5,451,958 | –F2 | – | 26,332,958 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 19, 2021 | Common Stock | CConversionDisposed | −5,451,958 | –F2 | – | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The shares were received upon the automatic conversion of a convertible promissory note issued to Agenus Inc. by the issuer upon completion of the Issuer's initial public offering. The conversion rate of the note was equal to the quotient obtained by dividing (i) the amount due on the date of conversion by (ii) 80% of the per share price of the common stock sold in the initial public offering.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.